RecruitingNot ApplicableNCT07391683

Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome

Prospective, Randomized Open Label Trial of Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome

Sponsor

Medical University Innsbruck

Enrollment

162 participants

Start Date

Feb 16, 2026

Study Type

INTERVENTIONAL

Conditions

Patients With Heart Failure Undergoing Cardiac Surgery

Summary

Patients with heart failure undergoing cardiac surgery face a significantly increased perioperative risk, yet no standardized strategy exists to mitigate this risk effectively. Current preoperative management relies on optimization of medical therapy without a structured prehabilitation approach. Given the strong association between eleveated preoperative N-terminal pro-B-type natriuretic peptide levels and postoperative outcomes, patients at increased risk could be identified using this biomarker. Telemedical disease management programs have demonstrated efficacy in outpatient heart failure care, but their role in preoperative optimization remains underexplored. This study aims to assess whether a structured, multidisciplinary, telemedicine-assisted prehabilitation program can reduce perioperative complications, and improve surgical outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether using telemedicine to optimize a patient's health before scheduled heart surgery leads to better outcomes. Patients with elevated heart failure markers will be monitored remotely and have their medications adjusted before surgery. The goal is to reduce complications during and after the operation. **You may be eligible if...** - You are 18 or older - You are scheduled to have elective cardiac surgery (planned in advance, not emergency) - Your NT-proBNP level (a blood marker for heart stress) is 1500 ng/L or higher - You are able to measure your own vital signs at home or have someone who can help you - You are able to communicate adequately (language, vision, hearing) **You may NOT be eligible if...** - You have neuropsychiatric disorders, drug addiction, or alcohol abuse that would prevent reliable participation - You cannot use basic monitoring devices or transmit data - You are pregnant - You have severe kidney disease requiring dialysis - You are scheduled for a heart transplant or need a mechanical heart pump (LVAD) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPREPARE-HF disease management program, which includes:

1. Heart failure education and training 2. Optimization of guideline-directed medical therapy (GDMT) 3. Telemedical / telenursing / monitoring and therapy adjustments 4. Supervised telemedicine-assisted exercise program

Locations(1)

Medical University of Innsbruck - Department of Cardiology & Department of Cardiac Surgery

Innsbruck, Tyrol, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07391683